| Literature DB >> 36225302 |
Andrea Saponaro1, Francesca Vallese2,3,4, Alessandro Porro1, Oliver B Clarke2,3,4.
Abstract
Tetratricopeptide repeat-containing Rab8b-interacting (TRIP8b) protein is a brain-specific subunit of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels, a class of voltage-gated channels modulated by cyclic nucleotides. While the interaction between TRIP8b and the cytosolic C terminus of the channel has been structurally described, the HCN:TRIP8b stoichiometry is less characterized. We employed single molecule mass photometry (MP) to image HCN4 particles purified in complex with TRIP8b. Our data show that four TRIP8b subunits are bound to the tetrameric HCN4 particle, confirming a 1:1 stoichiometry.Entities:
Keywords: HCN channels; Ih current; TRIP8b; cAMP; mass photometry; stoichiometry
Year: 2022 PMID: 36225302 PMCID: PMC9549148 DOI: 10.3389/fphys.2022.998176
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Functional characterization of the inhibitory effect of TRIP8b on the HCN4 construct employed for MP. (A) Representative whole-cell current traces of HCN4 channels recorded, with 0.25 µM cAMP in the patch pipette, in HEK293T cells transiently expressing the channel alone (top) or with GFP-TRIP8b (1a) (bottom). Black arrows indicate the current selected for analysis in (B). (B) Mean activation curves of HCN4 channels alone (black full circles) or co-expressed with GFP-TRIP8b (1a) (black open circles) with cAMP in the patch pipette obtained from tail currents collected at −40 mV (see arrows in panel (A). Dashed lines indicate Boltzmann fitting to the data (see Materials and methods) from which the half activation potential (V1/2) were derived. HCN4 + cAMP = −76.9 ± 0.6 mV; HCN4 + TRIP8b + cAMP = −94.2 ± 1.2 mV. Data are presented as mean ± SEM. Number of cells (N) ≥ 8. The two half activation potentials are statistically different. Statistical analysis performed with t-student test (p < 0.001).
FIGURE 2Single molecule mass photometry of HCN4—EGFP-TRIP8b complex. (A) SEC of HCN4—EGFP-TRIP8b complex following purification in LMNG/CHS. Peak fractions used for MP are delimited by the red lines. (B) SDS-PAGE gel of the pooled SEC fractions of HCN4—EGFP-TRIP8b complex, stained with Coomassie blue. Filled arrows indicate HCN4, while open arrows indicate EGFP-TRIP8b, in their oligomeric (square bracket), and monomeric forms. (C) Western blots of the pooled SEC fractions of HCN4—EGFP-TRIP8b complex performed by using anti-TRIP8b and anti-HCN4 antibodies, respectively. Open and filled arrows as in panel (B). Of note that the western blot anti-TRIP8b reveals the presence of a small number of molecules (faint band between 60 and 50 kDa markers) corresponding N terminally degraded TRIP8b. Indeed, they co-purified with HCN4 and thus have retained the HCN binding sites located in their C-terminal half (Santoro et al., 2004; Santoro et al., 2011). (D) Mass histogram of binding events for HCN4—EGFP-TRIP8b complex before (left) and after the addition of 2 mM cAMP (right). The blue lines represent the fitting of the data with Gaussian Distribution Function. Left, schematic representation of purified HCN4 (green) embedded into a detergent micelle (yellow) and bound to four TRIP8b molecules (blue). Right, purified HCN4 bound to cAMP (red) has lost TRIP8b.